{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:42:49Z","timestamp":1791484969593,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:00:00Z","timestamp":1636502400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:00:00Z","timestamp":1636502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The relationship between the type of anesthesia and the survival outcomes of gastric cancer patients is uncertain. This study compared the overall outcome of gastric cancer patients after surgery with total intravenous anesthesia (TIVA) or inhalation anesthesia (IHA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Clinicopathological variables of gastric cancer patients were retrieved from the database of the Surgical Gastric Cancer Patient Registry in West China Hospital, Sichuan University. Patients were grouped according to whether they received TIVA or IHA during the operation. Propensity score (PS) matching was used to balance the baseline variables, and survival outcomes were compared between these two groups. In addition, studies comparing survival outcomes between TIVA and IHA used for gastric cancer surgery and published before April 20th, 2020, were identified, and their data were pooled.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 2827 patients who underwent surgical treatment from Jan 2009 to Dec 2016 were included. There were 323 patients in the TIVA group and 645 patients in the IHA group, with 1:2 PS matching. There was no significant difference in overall survival outcomes between the TIVA and IHA groups before matching the cohort (<jats:italic>p<\/jats:italic>\u00a0=\u20090.566) or after matching the cohort (<jats:italic>p<\/jats:italic>\u00a0=\u20090.679) by log-rank tests. In the Cox hazard regression model, there was no significant difference between the TIVA and IHA groups before (HR: 1.054, 95% CI: 0.881\u20131.262, <jats:italic>p<\/jats:italic>\u00a0=\u20090.566) or after (HR: 0.957, 95% CI: 0.779\u20131.177, <jats:italic>p<\/jats:italic>\u00a0=\u20090.679) PS matching. The meta-analysis of survival outcomes between the TIVA and IHA groups found critical statistical value in the before PS matching cohort (HR 0.74, 95% CI: 0.57\u20130.96 <jats:italic>p<\/jats:italic>\u00a0&lt;\u20090.01) and after PS matching cohort (HR: 0.65, 95% CI: 0.46\u20130.94, p\u2009&lt;\u20090.01).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Combined with the results of previous studies, total intravenous anesthesia has been shown to be superior to inhalation anesthesia in terms of overall survival for gastric cancer patients undergoing surgical treatment. The selection of intravenous or inhalation anesthesia for gastric cancer surgery should take into account the long-term prognosis of the patient.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-021-08946-7","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T10:02:50Z","timestamp":1636538570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The long-term survival outcomes of gastric cancer patients with total intravenous anesthesia or inhalation anesthesia: a single-center retrospective cohort study"],"prefix":"10.1186","volume":"21","author":[{"given":"Wei-Wei","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Han","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Zu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zong-Guang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Kun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,10]]},"reference":[{"issue":"12","key":"8946_CR1","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","volume":"5","author":"C Fitzmaurice","year":"2019","unstructured":"Global Burden of Disease Cancer C, Fitzmaurice C, Abate D, Abbasi N, Abbastabar H, Abd-Allah F, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5(12):1749\u201368.","journal-title":"JAMA Oncol"},{"issue":"2","key":"8946_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115\u201332. https:\/\/doi.org\/10.3322\/caac.21338.","journal-title":"CA Cancer J Clin"},{"key":"8946_CR3","doi-asserted-by":"publisher","unstructured":"Japanese Gastric Cancer A. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 20(1):1\u201319. https:\/\/doi.org\/10.1007\/s10120-016-0622-4.","DOI":"10.1007\/s10120-016-0622-4"},{"issue":"1","key":"8946_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10120-020-01042-y","volume":"24","author":"Japanese Gastric Cancer A","year":"2020","unstructured":"Japanese Gastric Cancer A. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. 2020;24(1):1\u201321.","journal-title":"Gastric Cancer"},{"issue":"31","key":"8946_CR5","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1200\/JCO.2012.41.8343","volume":"30","author":"DS Han","year":"2012","unstructured":"Han DS, Suh YS, Kong SH, Lee HJ, Choi Y, Aikou S, et al. Nomogram predicting long-term survival after d2 gastrectomy for gastric cancer. J Clin Oncol. 2012;30(31):3834\u201340. https:\/\/doi.org\/10.1200\/JCO.2012.41.8343.","journal-title":"J Clin Oncol"},{"issue":"1","key":"8946_CR6","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1038\/s41467-018-04907-0","volume":"9","author":"Y Shu","year":"2018","unstructured":"Shu Y, Zhang W, Hou Q, Zhao L, Zhang S, Zhou J, et al. Prognostic significance of frequent CLDN18-ARHGAP26\/6 fusion in gastric signet-ring cell cancer. Nat Commun. 2018;9(1):2447. https:\/\/doi.org\/10.1038\/s41467-018-04907-0.","journal-title":"Nat Commun"},{"issue":"3","key":"8946_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00540-008-0626-2","volume":"22","author":"S Kurosawa","year":"2008","unstructured":"Kurosawa S, Kato M. Anesthetics, immune cells, and immune responses. J Anesth. 2008;22(3):263\u201377. https:\/\/doi.org\/10.1007\/s00540-008-0626-2.","journal-title":"J Anesth"},{"issue":"5","key":"8946_CR8","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1213\/01.ANE.0000082995.44040.07","volume":"97","author":"R Melamed","year":"2003","unstructured":"Melamed R, Bar-Yosef S, Shakhar G, Shakhar K, Ben-Eliyahu S. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth Analg. 2003;97(5):1331\u20139. https:\/\/doi.org\/10.1213\/01.ANE.0000082995.44040.07.","journal-title":"Anesth Analg"},{"issue":"Suppl 1","key":"8946_CR9","doi-asserted-by":"publisher","first-page":"i56","DOI":"10.1093\/bja\/aeu200","volume":"113","author":"A Buckley","year":"2014","unstructured":"Buckley A, McQuaid S, Johnson P, Buggy DJ. Effect of anaesthetic technique on the natural killer cell anti-tumour activity of serum from women undergoing breast cancer surgery: a pilot study. Br J Anaesth. 2014;113(Suppl 1):i56\u201362. https:\/\/doi.org\/10.1093\/bja\/aeu200.","journal-title":"Br J Anaesth"},{"issue":"3","key":"8946_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230290","volume":"15","author":"HC Lai","year":"2020","unstructured":"Lai HC, Lee MS, Lin KT, Huang YH, Chen JY, Lin YT, et al. Propofol-based total intravenous anesthesia is associated with better survival than desflurane anesthesia in robot-assisted radical prostatectomy. PLoS ONE. 2020;15(3):e0230290. https:\/\/doi.org\/10.1371\/journal.pone.0230290.","journal-title":"PLoS ONE"},{"issue":"5","key":"8946_CR11","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1097\/ALN.0000000000002357","volume":"129","author":"ZF Wu","year":"2018","unstructured":"Wu ZF, Lee MS, Wong CS, Lu CH, Huang YS, Lin KT, et al. Propofol-based Total intravenous anesthesia is associated with better survival than Desflurane anesthesia in Colon Cancer surgery. Anesthesiology. 2018;129(5):932\u201341. https:\/\/doi.org\/10.1097\/ALN.0000000000002357.","journal-title":"Anesthesiology"},{"issue":"1","key":"8946_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/ALN.0000000000002491","volume":"130","author":"S Yoo","year":"2019","unstructured":"Yoo S, Lee HB, Han W, Noh DY, Park SK, Kim WH, et al. Total intravenous anesthesia versus inhalation anesthesia for breast Cancer surgery: a retrospective cohort study. Anesthesiology. 2019;130(1):31\u201340. https:\/\/doi.org\/10.1097\/ALN.0000000000002491.","journal-title":"Anesthesiology"},{"issue":"11","key":"8946_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224728","volume":"14","author":"YH Huang","year":"2019","unstructured":"Huang YH, Lee MS, Lou YS, Lai HC, Yu JC, Lu CH, et al. Propofol-based total intravenous anesthesia did not improve survival compared to desflurane anesthesia in breast cancer surgery. PLoS ONE. 2019;14(11):e0224728. https:\/\/doi.org\/10.1371\/journal.pone.0224728.","journal-title":"PLoS ONE"},{"key":"8946_CR14","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.2147\/OTT.S156792","volume":"11","author":"X Zheng","year":"2018","unstructured":"Zheng X, Wang Y, Dong L, Zhao S, Wang L, Chen H, et al. Effects of propofol-based total intravenous anesthesia on gastric cancer: a retrospective study. Onco Targets Ther. 2018;11:1141\u20138. https:\/\/doi.org\/10.2147\/OTT.S156792.","journal-title":"Onco Targets Ther"},{"issue":"9","key":"8946_CR15","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1111\/aas.13414","volume":"63","author":"TK Oh","year":"2019","unstructured":"Oh TK, Kim HH, Jeon YT. Retrospective analysis of 1-year mortality after gastric cancer surgery: Total intravenous anesthesia versus volatile anesthesia. Acta Anaesthesiol Scand. 2019;63(9):1169\u201377. https:\/\/doi.org\/10.1111\/aas.13414.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"25","key":"8946_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000020714","volume":"99","author":"NC Huang","year":"2020","unstructured":"Huang NC, Lee MS, Lai HC, Lin HT, Huang YH, Lu CH, et al. Propofol-based total intravenous anesthesia improves survival compared to desflurane anesthesia in gastric cancer surgery: a retrospective analysis. Medicine (Baltimore). 2020;99(25):e20714. https:\/\/doi.org\/10.1097\/MD.0000000000020714.","journal-title":"Medicine (Baltimore)"},{"key":"8946_CR17","doi-asserted-by":"publisher","unstructured":"Chen HN, Shu Y, Liao F, Liao X, Zhang H, Qin Y, et al. Genomic evolution and diverse models of systemic metastases in colorectal cancer. Gut. 2021:gutjnl-2020-323703. https:\/\/doi.org\/10.1136\/gutjnl-2020-323703.","DOI":"10.1136\/gutjnl-2020-323703"},{"issue":"9","key":"8946_CR18","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s12032-014-0150-1","volume":"31","author":"WH Zhang","year":"2014","unstructured":"Zhang WH, Chen XZ, Liu K, Chen XL, Yang K, Zhang B, et al. Outcomes of surgical treatment for gastric cancer patients: 11-year experience of a Chinese high-volume hospital. Med Oncol. 2014;31(9):150. https:\/\/doi.org\/10.1007\/s12032-014-0150-1.","journal-title":"Med Oncol"},{"key":"8946_CR19","doi-asserted-by":"crossref","unstructured":"Amin MB, Edge SB, Greene FL, et al. AJCC Cancer Staging Manual. 8th ed. NewYork: Springer; 2017.","DOI":"10.1007\/978-3-319-40618-3"},{"issue":"2","key":"8946_CR20","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/pst.433","volume":"10","author":"PC Austin","year":"2011","unstructured":"Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat. 2011;10(2):150\u201361. https:\/\/doi.org\/10.1002\/pst.433.","journal-title":"Pharm Stat"},{"issue":"4","key":"8946_CR21","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x20176803","volume":"51","author":"Q Du","year":"2018","unstructured":"Du Q, Liu J, Zhang X, Zhang X, Zhu H, Wei M, et al. Propofol inhibits proliferation, migration, and invasion but promotes apoptosis by regulation of Sox4 in endometrial cancer cells. Braz J Med Biol Res. 2018;51(4):e6803. https:\/\/doi.org\/10.1590\/1414-431x20176803.","journal-title":"Braz J Med Biol Res"},{"issue":"1","key":"8946_CR22","doi-asserted-by":"publisher","first-page":"11208","DOI":"10.1038\/s41598-020-67693-0","volume":"10","author":"G Fei","year":"2020","unstructured":"Fei G, Cao M, Ge C, Cui L. Propofol suppresses hepatocellular carcinoma by inhibiting NET1 through downregulating ERK\/VEGF signaling pathway. Sci Rep. 2020;10(1):11208. https:\/\/doi.org\/10.1038\/s41598-020-67693-0.","journal-title":"Sci Rep"},{"issue":"7","key":"8946_CR23","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1038\/bjc.2014.426","volume":"111","author":"H Huang","year":"2014","unstructured":"Huang H, Benzonana LL, Zhao H, Watts HR, Perry NJ, Bevan C, et al. Prostate cancer cell malignancy via modulation of HIF-1alpha pathway with isoflurane and propofol alone and in combination. Br J Cancer. 2014;111(7):1338\u201349. https:\/\/doi.org\/10.1038\/bjc.2014.426.","journal-title":"Br J Cancer"},{"key":"8946_CR24","doi-asserted-by":"publisher","first-page":"419","DOI":"10.12659\/MSM.899732","volume":"23","author":"CL Zhou","year":"2017","unstructured":"Zhou CL, Li JJ, Ji P. Propofol suppresses esophageal squamous cell carcinoma cell migration and invasion by Down-regulation of sex-determining region Y-box 4 (SOX4). Med Sci Monit. 2017;23:419\u201327. https:\/\/doi.org\/10.12659\/MSM.899732.","journal-title":"Med Sci Monit"},{"issue":"1","key":"8946_CR25","doi-asserted-by":"publisher","first-page":"14020","DOI":"10.1038\/s41598-017-14147-9","volume":"7","author":"IJ Jun","year":"2017","unstructured":"Jun IJ, Jo JY, Kim JI, Chin JH, Kim WJ, Kim HR, et al. Impact of anesthetic agents on overall and recurrence-free survival in patients undergoing esophageal cancer surgery: a retrospective observational study. Sci Rep. 2017;7(1):14020. https:\/\/doi.org\/10.1038\/s41598-017-14147-9.","journal-title":"Sci Rep"},{"issue":"2","key":"8946_CR26","doi-asserted-by":"publisher","first-page":"126","DOI":"10.4097\/kjae.2016.69.2.126","volume":"69","author":"JH Lee","year":"2016","unstructured":"Lee JH, Kang SH, Kim Y, Kim HA, Kim BS. Effects of propofol-based total intravenous anesthesia on recurrence and overall survival in patients after modified radical mastectomy: a retrospective study. Korean J Anesthesiol. 2016;69(2):126\u201332. https:\/\/doi.org\/10.4097\/kjae.2016.69.2.126.","journal-title":"Korean J Anesthesiol"},{"issue":"52","key":"8946_CR27","doi-asserted-by":"publisher","first-page":"90477","DOI":"10.18632\/oncotarget.21014","volume":"8","author":"MH Kim","year":"2017","unstructured":"Kim MH, Kim DW, Kim JH, Lee KY, Park S, Yoo YC. Does the type of anesthesia really affect the recurrence-free survival after breast cancer surgery? Oncotarget. 2017;8(52):90477\u201387. https:\/\/doi.org\/10.18632\/oncotarget.21014.","journal-title":"Oncotarget"},{"issue":"2","key":"8946_CR28","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","volume":"173","author":"KA Hoadley","year":"2018","unstructured":"Hoadley KA, Yau C, Hinoue T, Wolf DM, Lazar AJ, Drill E, et al. Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of Cancer. Cell. 2018;173(2):291\u2013304 e296. https:\/\/doi.org\/10.1016\/j.cell.2018.03.022.","journal-title":"Cell"},{"issue":"1","key":"8946_CR29","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12916-017-0900-y","volume":"15","author":"DR Caswell","year":"2017","unstructured":"Caswell DR, Swanton C. The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome. BMC Med. 2017;15(1):133. https:\/\/doi.org\/10.1186\/s12916-017-0900-y.","journal-title":"BMC Med"},{"issue":"1","key":"8946_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12876-015-0276-4","volume":"15","author":"ZB Shu","year":"2015","unstructured":"Shu ZB, Cao HP, Li YC, Sun LB. Influences of laparoscopic-assisted gastrectomy and open gastrectomy on serum interleukin-6 levels in patients with gastric cancer among Asian populations: a systematic review. BMC Gastroenterol. 2015;15(1):52. https:\/\/doi.org\/10.1186\/s12876-015-0276-4.","journal-title":"BMC Gastroenterol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08946-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08946-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08946-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T10:03:18Z","timestamp":1636538598000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08946-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,10]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8946"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08946-7","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,10]]},"assertion":[{"value":"6 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All methods of this study were carried out in accordance with relevant guidelines and regulations.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We collected data from the database of the Surgical Gastric Cancer Patient Registry in West China Hospital with the registration number WCH-SGCPR-2020. The approval to access and use the dataset was obtained from the Biomedical Ethical Committee of the West China Hospital, Sichuan University, China (No. 2014\u2013215). Patient records and personal information were deidentified before statistical analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from all participants, subjects under 16 years of age were not included in this trial.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1193"}}